Michael S Stalvey MD
Associate Professor, Assoc. Director for Research Affairs, University of Alabama at Birmingham
Join to View Full Profile
Medical Center BlvdWinston Salem, NC 27157
Phone+1 336-713-4500
Fax+1 336-713-4501
Dr. Stalvey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of FloridaFellowship, Pediatric Endocrinology, 2003 - 2006- University of FloridaResidency, Pediatrics, 1999 - 2002
- University of Florida College of MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2002 - 2026
AL State Medical License 2011 - 2025
NC State Medical License 2021 - 2025
MA State Medical License 2008 - 2011
American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study.Rosara Bass, Michael Stalvey, George Solomon, Steven Rowe, David Nichols
Journal of Clinical & Translational Endocrinology. 2025-06-01 - 3 citationsClinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis.Traci M Kazmerski, Olivia M Stransky, Danielle R Lavage, Kara S Hughan, Raksha Jain
Journal of Cystic Fibrosis. 2024-05-01 - 53 citationsElexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.Sarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, Lucas R Hoffman, Christopher Pope
Journal of Cystic Fibrosis. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
